PP
AXNX icon

PDT Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

PDT Partners’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,471
Closed -$2.28M – 734
2022
Q4 		$2.28M Sell
36,471
-1,822
-5% -$121K 0.37% 66
2022
Q3 		$2.7M Buy
+38,293
New +$2.64M 0.41% 32

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

PDT Partners's AXNX Position: Q1 2023 in Review

PDT Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2023, closing a stake of 36,471 shares — an estimated $2.28M sold.

PDT Partners first reported a position in AXNX in Q3 2022 and held it in 2 quarters. The position peaked at $2.7M in Q3 2022. 236 funds tracked by Wall St. Rank hold AXNX as of Q1 2023.

  • PDT Partners reported no remaining Axonics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 36,471 Axonics, Inc. Common Stock shares in Q1 2023, an estimated $2.28M.
  • PDT Partners first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • PDT Partners's Axonics, Inc. Common Stock position peaked at $2.7M in Q3 2022.
  • 236 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.